Ocugen, Inc.
OCGNNasdaqCIK 1372299HealthcareFiscal year ends Dec 31
Reports and events: 362 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1512:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115970 |
| 2026-10-1501:22 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115921 |
| 2026-10-0621:36 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-065077 |
| 2026-09-2321:34 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-063084 |
| 2026-09-0821:27 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-105968 |
| 2026-08-0616:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054057 |
| 2026-08-0612:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091691 |
| 2026-07-3020:30 ET | DEF 14A | Proxy statementPeriod 2026-09-21 | 0001140361-26-030258 |
| 2026-07-1312:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-082897 |
| 2026-06-1121:19 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-26-073015 |
| 2026-06-0320:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-070124 |
| 2026-05-1420:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-26-061241 |
| 2026-05-1420:30 ET | 8-K | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-061230 |
| 2026-05-0823:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032454 |
| 2026-05-0720:12 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-057138 |
| 2026-05-0515:37 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-055411 |
| 2026-05-0420:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-054866 |
| 2026-04-2811:00 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001140361-26-017260 |
| 2026-03-2723:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-021541 |
| 2026-03-2416:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-033724 |
| 2026-03-2012:00 ET | 8-K | 8.01 Other events | 0001104659-26-032442 |
| 2026-03-0416:38 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-014435 |
| 2026-03-0416:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-023290 |
| 2026-03-0416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-023288 |
| 2026-02-0912:59 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-011765 |
| 2026-01-2313:12 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006031 |
| 2026-01-2122:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-005454 |
| 2026-01-1513:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-003900 |
| 2025-12-1822:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-122610 |
| 2025-11-0514:41 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001372299-25-000013 |
| 2025-11-0512:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-106664 |
| 2025-09-1815:00 ET | 8-K | 1.02 Termination of a material agreement | 0001104659-25-091097 |
| 2025-09-1623:50 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-25-090113 |
| 2025-09-0520:11 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-25-087801 |
| 2025-08-1112:35 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-075956 |
| 2025-08-0412:29 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-037310 |
| 2025-08-0116:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-072992 |
| 2025-07-3020:36 ET | 8-K | 8.01 Other events | 0001104659-25-072197 |
| 2025-07-2910:30 ET | 8-K | 8.01 Other events | 0001104659-25-071374 |
| 2025-07-0119:49 ET | 8-K | 3.01 Delisting notice | 0001104659-25-064695 |
| 2025-06-2312:58 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-061435 |
| 2025-06-1721:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001372299-25-000004 |
| 2025-06-0520:37 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-056875 |
| 2025-05-0913:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-024095 |
| 2025-05-0913:43 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-024093 |
| 2025-05-0113:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-021359 |
| 2025-04-2520:56 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001140361-25-015803 |
| 2025-04-2520:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-039478 |
| 2025-04-0413:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-016700 |
| 2025-03-0514:42 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-010271 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.